ALLE vs TSHA · P/E 21, rev $2.19B vs $640.7M cap
Allegion PLC (ALLE) versus Taysha Gene Therapies Inc (TSHA) — a side-by-side from cached financials, not a winner call.
Allegion PLC (ALLE) is a security & protection services company listed on US.
Taysha Gene Therapies Inc (TSHA) is a biotechnology company listed on US.
Latest reported ALLE revenue for 2026-06-30 was $2.19B. Net income was $322.7M. ALLE currently screens at market cap $12.71B and trailing P/E 20.7.
Latest reported TSHA revenue for 2026-06-30 was $0. Net income was -$89.0M. TSHA currently screens at market cap $640.7M.
ALLE currently screens at market cap $12.71B and trailing P/E 20.7. TSHA currently screens at market cap $640.7M.
Not investment advice. Open the ALLE and TSHA stock pages for the full models.
Not investment advice.